Nina Gårevik
Nina Gårevik at the Swedish Red Cross University.
Foto: RKH
Name: Nina Gårevik
Title: PhD, Lecturer, RN
Department: Department of Health Sciences
Phone: +46(0)8 - 587 516 12
E-mail: nina.garevik@rkh.se
ORCID: 0000-0003-4308-5828
Dissertation year: 2013
Thesis: Quantitative influence of exogenous androgens on serum lipid profile and endocrine functions.
About me
I have been working as a nurse in psychiatric care since 1990. I have devoted most of my clinical professional life to emergency psychiatric care. I have also been interested in patient safety issues in Psychiatric Healthcare. In 2018 I started teaching at Karolinska Institutet and in 2021 and for two years I was head of the unit at the same division, (Division of Nursing, Karolinska Institutet). 2023 I started teaching at the Swedish Red Cross University.
Research profile
My research is based on the dissertation work I carried out in 2009–2013 at the Department of Laboratory Medicine, Karolinska Institutet. My studies focused on unwanted effects of anabolic androgenic steroids in men such as; hormonal side effects, blood lipid disorders but also abuse patterns such as other co-abused preparations and age of onset. My interest has been to study doping among persons who are not connected to sports associations, for example young gym goers. A problem related to and sometimes directly linked to mental illness and body ideals. After my dissertation, I have continued my research on the side effects of these preparations. It has been shown in research that thoughts about what the body should look like, and body ideals begin at an early age. I now have ongoing research collaborations that concentrate on young people and their conditions, opportunities, and prerequisites for mental health. I am collaborating in this research with researchers at the Karolinska Institutet and with researchers at the Public Health Agency of Sweden. Another future area of interest is pharmaceuticals for mental illness and especially antipsychotic drugs, primarily subjectively experienced side effects that may affect quality of life (subjectively experienced and expertly reviewed), cognition and the person's own experience of the treatment.
Brief facts
- Authored of about 15 articles
- Election committee RSMH (National Association for Social and Mental Health)
Publication
PubMed: selected
Börjesson A, Möller C, Hagelin A, Vicente V, Rane A, Lehtihet M, Dahl ML, Gårevik N, Ekström L. Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts and Criminality. Medicina (Kaunas). 2020 May 28;56(6):265. doi: 10.3390/medicina56060265.
Börjesson A, Gårevik N, Dahl ML, Rane A, Ekström L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abuse Treat Prev Policy. 2016; 5;11(1):11. doi: 10.1186/s13011
Gårevik N, Börjesson A, Choong E, Ekström L, Lehtihet M. Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men. Andrologia. 2015; 15. doi: 10.1111/and.12488.
Gårevik N, Rane A, Björkhem-Bergman L, Ekström L. Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men. Subst Abuse Rehabil. 2014 Dec 10;5:121-7. doi: 10.2147/SAR.S71285
Gårevik N, Strahm E, Garle M, Lundmark J, Ståhle L, Ekström L, Rane A , Long term pertubation of endocrine parameters and cholesterol meatbolism after discontinued abuse of anabolic androgenic steroids, J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):295-300
Gårevik N, Rane A, Dual use of anabolic-androgenic steroids and narcotics in Sweden, Drug Alcohol Depend. 2010 Jun 1;109(1-3):144-6